Pharmaceuticals & Drugs
WOCKPHARMA
Wockhardt Ltd.
Wait and Watch
Setup readiness
Early Trend
- Entry Zone
- ₹1953.8-2434.4
- Support Level
- ₹2221.7
- Resistance
- ₹2906.8
- Risk / Reward
- 2.2 : 1
- Risk Distance
- 8.7% to stop
Reference levels for educational study only. Not a recommendation to buy or sell.
Swing Edge Intelligence
Structured setup analysis · research only
Setup status · Developing setup
Some constructive elements are present, but leadership and breakout quality remain mixed.
Bullish factors
- MACD below zero — weak trend (−2).
- Price remains distant from the pivot — breakout readiness is low.
- Reasonable 52w-high proximity (-17% below).
- 1 prior pivot rejection in last 60d (-8 pts).
- Price compression 0.33x — range contracted to 40% of normal.
- RS rank 94 — overowned (NSE: 21-25% win rate, operators distribute here).
- RSI 62 — ideal setup zone.
- Higher lows — buyers defending successive pullbacks.
- Distribution pressure visible across recent sessions.
- Volume flow suggests quiet institutional accumulation.
Risk factors
- Stop is 9% away — too wide to size well for a swing
Why not 100?
- Volume quality is not in top confirmation range yet
Overall view
Broader structure continues to reflect distribution rather than sustained demand. The setup is still developing — leadership and trend alignment need further confirmation.
Trade management framework
Research framework only. Use your own risk controls.
- If price moves +1R, consider reducing downside by moving stop closer to entry.
- If price reaches around +1.5R to +2R, consider partial profit booking (for example 20-30%).
- If trend extends beyond +2R, consider trailing below a fast trend reference (for example 21 EMA).
Setup research
WOCKPHARMA — trend, RS & risk snapshot (not a trade recommendation)
Signal · context · invalidation · risk · skip reasons — research only
Why now
Building toward the pivot (17% below)
- Volume drying up into the base — supply fading
- Confirmed Stage 2 uptrend
Context & regime
- Market regime Mixed / range-bound
- Trend stage Stage 2 — tradable
- Sector Mid-pack (#26/42)
- Relative strength Leader (RS 94)
- Trend strength Strong (ADX 38)
What invalidates it
This idea is wrong below ₹2221.7 (-10.3% away)
Base / stop support breaks — the swing thesis is wrong below here
- Stop / base low₹2221.7
- Pivot — failure re-entry below₹2422.3
Risk distance
Risk ≈ ₹212.7/share from entry ₹2434.4.
Stop is wide (9%) for a swing — sizing will be small
Reasons to skip 1
Disqualifiers that apply even if the score looks good.
- Stop is 9% away — too wide to size well for a swing
WOCKPHARMA Support & Resistance Levels
Research chart
Daily price action with entry, stop, and target levels from our latest scan, plus relative strength vs Nifty.
Entry zone, stop and targets are drawn on the price chart. · Research only.
Sector RS rank · latest scan
Loading peer comparison…
Trader brief
What to understand
WOCKPHARMA Entry, Stop-Loss & Targets
Research heuristic · not a buy/sell call
Low scanner score suggests weak or incomplete structure. Use this page for context, not as a primary trade candidate until the score and trend improve.
AI insights
AI Insights
Generated with AIThese insights are AI-generated to support your research process and should not be treated as investment advice or a recommendation to buy or sell securities.
Sign in to unlock AI Insights
Personalised swing trade analysis powered by Gemini AI
Pattern context 52w · setup · flow
52-week range
—Stage-2 ideal band · Early recovery
Setup highlights
Pattern signals from the latest scan
Smart money flow
Last 60 sessions · accumulation vs distribution
Setup intelligence Overhead · VCP · radar · risk
Overhead supply
Resistance ceiling above current price
Chase / failure risk
Honest read on exhaustion & extended moves
Base / VCP coil
Depth, contractions & pivot distance
Setup quality radar
Shape of the setup in one view
Setup metrics Weak
WOCKPHARMA Technical Analysis & Swing Setup
Grouped structure, momentum and risk from the latest research scan.
Structure
Momentum
Risk
More scanner fields
Peer comparison Sector peers
Sector Peer Comparison
Loading sector peers…
WOCKPHARMA FAQ Common swing-trading questions
Frequently asked questions about WOCKPHARMA
Is WOCKPHARMA a good swing trade right now?
On Swing Edge's swing-setup framework, Wockhardt Ltd. (WOCKPHARMA) currently grades A — high-quality setup. Building toward the pivot (17% below). Flagged today. This is educational research, not investment advice.
What are WOCKPHARMA's support and resistance levels?
For WOCKPHARMA, near-term support sits around ₹2,221.7 (the base/stop zone); overhead resistance is around ₹2,422.3 (the breakout pivot); the next resistance above is ₹2,906.8. This is educational research, not investment advice.
What is the breakout / pivot level for WOCKPHARMA?
The breakout pivot for WOCKPHARMA is around ₹2,422.3. Price is about 16.9% below the pivot and still building toward it. A breakout is typically confirmed on a close above the pivot with above-average volume. This is educational research, not investment advice.
Is WOCKPHARMA above its 50-day and 200-day moving averages?
Yes — WOCKPHARMA is in a confirmed Stage 2 uptrend, trading above its rising 50- and 200-day moving averages, the zone where swing setups tend to work best. This is educational research, not investment advice.
How strong is WOCKPHARMA versus the market (RS rank)?
WOCKPHARMA has a relative strength (RS) rank of 94 out of 100 versus the NSE universe, making it a market leader — stronger than most NSE stocks. Trend strength (ADX) reads 38, indicating a strong trend. This is educational research, not investment advice.
What are the entry, stop-loss and target levels for WOCKPHARMA?
Reference swing levels for WOCKPHARMA: entry around ₹2,434.4, stop-loss around ₹2,221.7, targets at ₹2,906.8 and ₹3,941.2. That works out to roughly a 2.2:1 reward-to-risk on the first target. These are reference levels for study only — this is educational research, not investment advice.
Answers are generated from Swing Edge's latest scan data and are for research only — not investment advice.
Prices and day-change figures use the last daily close from scan data dated 2026-06-22 — not live intraday NSE quotes.